Skip to main content
Caplight Logo









AQYLA BioVentures

AQYLA BioVentures

Private
BrusselsHealthcare & Life Scienceshttps://aqyla.bio

Company Overview

AQYLA BioVentures operates in Healthcare & Life Sciences and is based in Brussels.

AQYLA BioVentures is a European TechBio venture builder that develops biological theses and internal target origination before launching dedicated development subsidiaries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

AQYLA BioVentures Comparables

Compare AQYLA BioVentures with similar companies based on industry and business-model similarity.

AQYLA BioVentures comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Argobio
83%
Remora Biotech
76%
Agbiopro
60%
Book a demo to see all comparables

For institutional investors. Book with your work email.

AQYLA BioVentures Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for AQYLA BioVentures. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

AQYLA BioVentures Filings

Explore SEC and related filing metadata, where available.

AQYLA BioVentures filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about AQYLA BioVentures's valuation, stock price, and market status.

Is AQYLA BioVentures a public or private company?

AQYLA BioVentures is a private company.

What is the current stock price of AQYLA BioVentures?

AQYLA BioVentures is a private company, so its shares have no public market price. Caplight tracks AQYLA BioVentures's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is AQYLA BioVentures worth (valuation)?

Valuation information for AQYLA BioVentures is not publicly available.

Can I buy AQYLA BioVentures stock?

AQYLA BioVentures shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was AQYLA BioVentures's last funding round?

Funding round information for AQYLA BioVentures is not publicly available.

Who are the main investors in AQYLA BioVentures?

Investor information for AQYLA BioVentures is not publicly disclosed.

Will AQYLA BioVentures IPO soon?

No public IPO plans have been announced for AQYLA BioVentures.

How can I track AQYLA BioVentures secondary market activity?

Caplight tracks bids, offers, and trades in AQYLA BioVentures's shares on secondary markets.

Firmographic Details

HeadquartersBrussels
Year FoundedN/A
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?